Literature DB >> 13271133

Use of nitrogen mustard in treatment of serous effusions of neoplastic origin.

A S WEISBERGER, B LEVINE, J P STORAASLI.   

Abstract

Entities:  

Keywords:  NEOPLASMS/complications; NITROGEN MUSTARDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 13271133     DOI： 10.1001/jama.1955.02960350004002

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  29 in total

Review 1.  Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

Authors:  Kenneth Jaaback; Nick Johnson; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Nitrogen mustard in palliation of mslignant effusions.

Authors:  V B LEVISON
Journal:  Br Med J       Date:  1961-04-22

3.  Nitrogen mustard in treatment of pleural and peritoneal effusions.

Authors:  C W FULLERTON; P I REED
Journal:  Can Med Assoc J       Date:  1958-08-01       Impact factor: 8.262

4.  Office-based intraperitoneal chemotherapy for ovarian cancer.

Authors:  William R Robinson; Cathy Coberly; Julie Beyer; April Lewis; Carrie Ballard
Journal:  J Oncol Pract       Date:  2008-09       Impact factor: 3.840

Review 5.  Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.

Authors:  César P Ramírez Plaza; Manuel A Cobo Dols; Alberto Gómez Portilla; Agustín de la Fuente Perucho
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

6.  Nitrogen Mustard in Malignant Effusions.

Authors: 
Journal:  Can Med Assoc J       Date:  1956-02-15       Impact factor: 8.262

Review 7.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 8.  Update in cancer chemotherapy, Part IV. Lung cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-11       Impact factor: 1.798

Review 9.  Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.

Authors:  Csilla Hasovits; Stephen Clarke
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

Review 10.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence.

Authors:  Wim P Ceelen; Michael F Flessner
Journal:  Nat Rev Clin Oncol       Date:  2009-12-15       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.